ORGANIGRAM GLOBAL INC.
OGI · XNASCIK 1620737fmd_1GWM3YXJW00DA19ZS37CRAYYJ8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 01, 2017 to Sep 30, 2024, 6 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | 12 | 80 | 87 | 79 | 146 | 160 |
| Cost of revenue | 6 | 43 | 105 | 104 | 119 | 111 |
| Gross profit | 52 | 48 | (56) | (28) | 32 | 48 |
| Research and development | 0 | 0 | 1 | 4 | 6 | 11 |
| Selling, general and administrative | 6 | 19 | 28 | 30 | 43 | 46 |
| Operating income | 36 | 5 | (146) | (92) | (43) | (36) |
| Interest expense | 10 | 10 | 6 | 3 | 0 | – |
| Income before taxes | 28 | (6) | (147) | (131) | (14) | (45) |
| Income tax expense | 6 | 4 | (10) | 0 | (0) | 0 |
| Net income from continuing operations | 22 | (10) | (136) | (131) | (14) | (45) |
| Net income | 21 | (10) | (136) | (131) | (14) | (45) |